Size exclusion chromatography as a technique for the investigation of novel extracellular vesicles in cancer
File(s)cancers-12-03156-v2.pdf (3 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Abstract: (1) Background: Cancer cells release extracellular vesicles that are a rich target for biomarker discovery and provide a promising mechanism for liquid biopsy. SEC is an increasingly popular technique which has been rediscovered for the purposes of EV isolation and purification from diverse biofluids. (2) Methods: A review was undertaken to identify all papers which described size exclusion as their primary EV isolation method in cancer research. (3) Results: 37 papers were identified and discussed which showcases the breadth of applications that EVs can be utilised, from proteomics, to RNA, and through to functionality. A range of different methods are highlighted, with Sepharose-based techniques predominating. (4) Conclusions: EVs isolated using SEC are able to identify cancer cells, highlight active pathways in tumourigenesis, clinically distinguish cohorts and remain functionally active for further experiments.
Date Issued
2020-10-27
Date Acceptance
2020-10-15
Citation
Cancers, 2020, 12 (11)
ISSN
2072-6694
Publisher
MDPI AG
Journal / Book Title
Cancers
Volume
12
Issue
11
Copyright Statement
©2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open accessarticle distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license (http://creativecommons.org/licenses/by/4.0/)
License URL
Sponsor
Royal College Of Surgeons Of England
Royal College of Surgeons Edinburgh
J P Moulton Charitable Foundation
Mason Medical Research Foundation
Grant Number
WSCC_P83671
SPPG/17/107
N/A
N/A
Subjects
SEC
biomarkers
cancer
exosomes
extracellular vesicles
size-exclusion chromatography
1112 Oncology and Carcinogenesis
Publication Status
Published
Article Number
ARTN 3156